Stockscreener 앱 받기
1.35
0.00%
0.00
시간 외 거래:
1.37
0.02
+1.48%
전일 마감가:
$1.35
열려 있는:
$1.34
하루 거래량:
1.48M
Relative Volume:
0.49
시가총액:
$1.07B
수익:
$711.41M
순이익/손실:
$-133.73M
주가수익비율:
-7.1053
EPS:
-0.19
순현금흐름:
$-199.99M
1주 성능:
+9.76%
1개월 성능:
+0.75%
6개월 성능:
-17.68%
1년 성능:
-11.76%
1일 변동 폭
$1.32
$1.37
1주일 범위
$1.23
$1.37
52주 변동 폭
$1.11
$2.035
Opko Health Inc Stock (OPK) Company Profile
명칭
Opko Health Inc
전화
305-575-4181
주소
4400 BISCAYNE BLVD., MIAMI, FL
OPK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.35 | 1.07B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
485.04 | 183.06B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
210.22 | 149.76B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
653.95 | 53.12B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
118.87 | 34.17B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
189.40 | 32.34B | 15.50B | 1.33B | 2.16B | 7.34 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-25 | 개시 | JP Morgan | Neutral |
| 2023-06-29 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | 개시 | H.C. Wainwright | Buy |
| 2022-01-24 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | 개시 | Ladenburg Thalmann | Buy |
| 2019-11-25 | 개시 | Piper Jaffray | Overweight |
| 2018-03-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-09-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2016-06-21 | 재확인 | Standpoint Research | Buy |
| 2016-06-03 | 개시 | Standpoint Research | Buy |
| 2016-03-31 | 재확인 | Barrington Research | Outperform |
| 2015-10-16 | 개시 | JP Morgan | Overweight |
| 2015-09-11 | 다운그레이드 | Jefferies | Buy → Hold |
| 2015-03-03 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2014-05-12 | 재확인 | Oppenheimer | Outperform |
| 2014-03-14 | 개시 | Oppenheimer | Outperform |
| 2013-11-13 | 재확인 | Ladenburg Thalmann | Buy |
| 2013-05-30 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-10-22 | 개시 | Barrington Research | Outperform |
| 2011-12-01 | 재확인 | Ladenburg Thalmann | Buy |
| 2011-07-14 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Opko Health Inc 주식(OPK)의 최신 뉴스
How OPKO Health Inc. stock performs during market volatilityJuly 2025 Setups & Stepwise Swing Trade Plans - sundaytimes.kr
Phillip Md Et Al Frost Purchases 675,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock - MarketBeat
OPKO Health (NASDAQ:OPK) Shares Gap Up Following Insider Buying Activity - MarketBeat
OPKO Health’s (OPK) Oral GLP-2 Analog Selected for a Poster Presentation in Collaboration with Entera Bio (ENTX) - MSN
Y.D. More Investments Ltd Has $2.97 Million Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Is OPKO Health Inc. affected by consumer sentimentBreakout Stocks with Huge Upside - newsyoung.net
Phillip Frost Spends US$891k On OPKO Health Stock - simplywall.st
Phillip Frost Buys Handful Of Shares In OPKO Health - ca.finance.yahoo.com
OPKO Health Q3 EPS Estimate Reduced by Barrington Research - MarketBeat
Phillip Frost's Significant Investment in Opko Health: A Bold Move - AInvest
Opko Health’s CEO Makes a Bold Move with Massive Stock Purchase! - TipRanks
Quote - OPKO Health, Inc.
Entera Bio Beats Q2 EPS Estimates - The Motley Fool
Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates - GlobeNewswire
Opko Health (OPK) Q2 Revenue Falls 14% - AOL.com
OPKO Health (OPK) Q2 2025 Earnings Call Transcript - AOL.com
OPKO Health, Inc. (NASDAQ:OPK) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
OPKO Health (NASDAQ:OPK) Sets New 52-Week Low on Disappointing Earnings - MarketBeat
Acromegaly Pipeline 2025: Key Companies, MOA, ROA, and Clinical - openPR.com
Opko Health (OPK) Reports Fiscal Q2 2025 Results - Insider Monkey
Optimistic Growth Prospects for OPKO Health: Buy Rating with 89% Upside Potential - TipRanks
Can OPKO Health Inc. Outperform Peers After Recent PullbackAccurate Technical Trend Reversal Picks Detected - metal.it
What analysts say about OPKO Health Inc. stockFree Stock Index Interpretation - Jammu Links News
What is the dividend policy of OPKO Health Inc. stockInvest confidently with data-backed picks - Jammu Links News
OPKO Health Inc. Stock Analysis and ForecastUnrivaled growth potential - Jammu Links News
What drives OPKO Health Inc. stock priceBuild wealth steadily with smart stock selection - Jammu Links News
What makes OPKO Health Inc. stock price move sharplyOutstanding investment returns - Jammu Links News
What is OPKO Health Inc. company’s growth strategyMaximize gains with professional stock picks - Jammu Links News
What are the latest earnings results for OPKO Health Inc.Achieve breakthrough performance with smart picks - Jammu Links News
Is OPKO Health Inc. a growth stock or a value stockUnlock exclusive stock market forecasts - Jammu Links News
Why is OPKO Health Inc. stock attracting strong analyst attentionSuperior stock growth - Jammu Links News
How many analysts rate OPKO Health Inc. as a “Buy”Phenomenal wealth increase - Jammu Links News
Is it the right time to buy OPKO Health Inc. stockBuild a diversified portfolio for risk mitigation - Jammu Links News
OPKO Health (OPK.O) Plummets 7% Amid Oversold RSI and Weak Sector Sentiment - AInvest
What is the risk reward ratio of investing in OPKO Health Inc. stockGet exclusive market insights for better trading - Jammu Links News
What institutional investors are buying OPKO Health Inc. stockMaximize portfolio value with smart investment plans - Jammu Links News
What are OPKO Health Inc. company’s key revenue driversGet alerts on top growth stocks daily - Jammu Links News
OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands - MSN
OPKO Health Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
GSA Capital Partners LLP Boosts Stock Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
OPKO Health (OPK.O) Plunges 9.77%: What's Behind the Sharp Intraday Drop? - AInvest
OPKO Health's Strategic Asset Sale to Labcorp: A Financial Boost and Strong Analyst Expectations - AInvest
Opko Health Inc (OPK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.12%
0.47%
자본화:
|
볼륨(24시간):